We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trial Investigates Alpha-1-Antitrypsin for Severe COVID-19 Infection

News   Jun 30, 2020 | Original story from RCSI University of Medicine and Health Sciences

 
Clinical Trial Investigates Alpha-1-Antitrypsin for Severe COVID-19 Infection
 
 
Advertisement
 

RELATED ARTICLES

COVID-19 Could Outwit Science Unless Knowledge Stays Current

News

The virus that causes COVID-19 has many variants, and if scientists don’t stay on top of how it is changing in different parts of the world, testing for it may produce false negative results.

READ MORE

Probiotics May Help To Alleviate Depression

News

Probiotics either taken by themselves or when combined with prebiotics, may help to ease depression, suggests a new review, although further investigation is needed.

READ MORE

Using E. coli To Fight E.coli

News

Nissle, a strain of E. coli, is harmless to intestinal tissue and may protect the gut from enterohemorrhagic E. coli, a pathogen that produces Shiga toxin.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE